CAPTRUST Financial Advisors
RYTM icon

CAPTRUST Financial Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History

CAPTRUST Financial Advisors’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.58M Sell
18,147
-178
-1% -$17.3K ﹤0.01% 1331
2025
Q4 		$1.96M Buy
18,325
+67
+0.4% +$7.11K ﹤0.01% 1108
2025
Q3 		$1.84M Buy
18,258
+787
+5% +$73.1K ﹤0.01% 1068
2025
Q2 		$1.1M Buy
17,471
+114
+0.7% +$6.98K ﹤0.01% 1303
2025
Q1 		$919K Buy
+17,357
New +$963K ﹤0.01% 1324
2021
Q4 		– Sell
-19
Closed – – 4891
2021
Q3 		$0 Sell
19
-12
-39% -$183 ﹤0.01% 4741
2021
Q2 		$1K Hold
31
– – ﹤0.01% 4377
2021
Q1 		$1K Buy
+31
New +$899 ﹤0.01% 4231

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

CAPTRUST Financial Advisors's RYTM Position: Q1 2026 in Review

CAPTRUST Financial Advisors reduced its Rhythm Pharmaceuticals (RYTM) stake by 0.97% in Q1 2026, selling an estimated $17.3K and leaving 18,147 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1331.

CAPTRUST Financial Advisors first reported a position in RYTM in Q1 2021 and has held it in 8 quarters since. The position peaked at $1.96M in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • CAPTRUST Financial Advisors held 18,147 shares of Rhythm Pharmaceuticals worth $1.58M as of Q1 2026.
  • CAPTRUST Financial Advisors sold 178 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $17.3K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #1331 holding.
  • CAPTRUST Financial Advisors first reported a position in Rhythm Pharmaceuticals in Q1 2021 and has held it in 8 quarters since.
  • CAPTRUST Financial Advisors's Rhythm Pharmaceuticals position peaked at $1.96M in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.